Lataa...
Hydroxychloroquine Inhibits Cardiac Conduction in Aged Patients with Nonmalaria Diseases
BACKGROUND: The COVID-19 pandemic has brought increased focus on hydroxychloroquine (HCQ), as doctors, the medical community, and policymakers around the world attempt to understand how the risks of HCQ weigh against unknown benefits. We aim to evaluate the effects of HCQ on cardiac conduction, thus...
Tallennettuna:
| Julkaisussa: | Kidney Dis (Basel) |
|---|---|
| Päätekijät: | , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
S. Karger AG
2021
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8089424/ https://ncbi.nlm.nih.gov/pubmed/34192120 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000515278 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|